Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Finding of Mean Corpuscular Hemoglobin
|
1206 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||
Portal cirrhosis
|
4 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.700 | 1.000 | 1 | 2015 | 2015 | ||||
Precursor Cell Lymphoblastic Leukemia Lymphoma
|
168 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||
RDW - Red blood cell distribution width result
|
988 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||
Red cell distribution width determination
|
988 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||
Serum total cholesterol measurement
|
1243 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.700 | 1.000 | 1 | 2018 | 2018 | ||||
22q13.3 Deletion Syndrome
|
10 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Adult Hepatocellular Carcinoma
|
14 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
alcohol-related liver disease
|
2 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Alcoholic Intoxication, Chronic
|
441 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Asthma
|
1536 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Carotid Atherosclerosis
|
79 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Celiac Disease
|
263 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Childhood Hepatocellular Carcinoma
|
17 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
Cholestasis of pregnancy
|
24 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Chronic Kidney Diseases
|
306 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Chronic Liver Failure
|
1 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Chronic viral hepatitis
|
8 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
End Stage Liver Disease
|
3 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Gestational Diabetes
|
224 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
HCV coinfection
|
5 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Hepatitis
|
42 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Hepatitis, Chronic
|
10 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
Hepatocarcinogenesis
|
24 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
HIV Infections
|
142 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.010 | 1.000 | 1 | 2014 | 2014 |